Di-peptide synthesis simplified
Kyowa Hakko Kogyo has developed a new process for manufacturing amino acid dimers - also known as di-peptides - that could increase their use as components in infusions and enteral nutrition products.
Archives for September 20, 2004
Biogenerics debate rumbles on
Representatives of the pharmaceutical and biotechnology industries presented strong opposition to the concept of biogenerics at a recent meeting convened by the US Food and Drug Administration. As expected, their argument centred on the risk that...
Powder testing goes automatic
Freeman Technology is gearing up to launch the first in a new range of accessories for its FT4 powder rheometer that are designed to bring it into the age of industrial automation.
Peptisyntha increases US peptide capacity
Solvay subsidiary Peptisyntha is boosting its capacity to make peptides at its facilities in California, US, in anticipation of increasing numbers of drugs in this class coming through to market.
Roche licenses humanising antibody technology
Drug major Roche has licensed a technology developed by Glycart Biotechnology that makes antibody-based drugs more effective by making them resemble natural human antibodies more closely.